Two prescription weight loss injectable treatments are available through MedExpress: Mounjaro® and Wegovy®. Both support weight loss and appetite control, but they work differently and may suit different patients.
Overview
This article explains:
The key differences between Mounjaro® and Wegovy®.
How each medication works.
How effectiveness compares when used with consistent lifestyle support.
Guidance on treatment choices and switching.
How Mounjaro® and Wegovy® Work
Mounjaro® (tirzepatide)
Mounjaro® targets two hormones (GIP and GLP-1) to reduce appetite and cravings, slow stomach emptying, and improve blood sugar control. When used alongside consistent lifestyle support, clinical trials indicate an average weight loss of approximately 20% of starting body weight.
Wegovy® (semaglutide)
Wegovy® targets one hormone (GLP-1) to increase feelings of fullness and reduce calorie intake. Clinical results vary based on the maintenance dose used alongside consistent lifestyle support:
Wegovy® 2.4 mg: Average weight loss of approximately 15%.
Wegovy® 7.2 mg: Average weight loss of approximately 20%.
Key Differences at a Glance
Feature | Mounjaro® | Wegovy® |
Hormones Targeted | GLP-1 + GIP (dual action) | GLP-1 only |
Average Weight Loss | ~20% | ~15–20% (dose dependent) |
Clinical Profile | Highly effective dual action | Highly effective GLP-1 agonist |
Both medications are considered on par with one another in terms of their ability to support significant, clinically meaningful weight loss.
Choosing or Switching Treatments
When to Stay on Your Current Treatment
You may prefer to stay on your current medication if you are seeing consistent progress, side effects are manageable, and the treatment remains affordable. Staying on your current plan avoids the adjustment periods associated with changing medications or dosing routines.
When to Consider Switching
You might consider a switch if you are looking for a more cost-effective option, prefer a different treatment profile, or wish to continue your progress with an alternative.
Why choose Wegovy®?
In addition to its proven weight management efficacy, Wegovy® is:
Clinically proven and widely used.
A strong alternative for long-term weight management.
Associated with additional evidence for cardiovascular benefits.
How the Right Treatment is Chosen
A MedExpress prescriber will recommend the most suitable option based on:
Your BMI and medical history.
Previous use of GLP-1 medications.
Your tolerance to side effects.
Your specific weight loss goals.
Current safety and clinical guidelines.
Switching Between Treatments
Switching between Mounjaro® and Wegovy® is a standard clinical process. If you decide to switch:
Your clinician will recommend the appropriate starting dose.
You will receive clear guidance to ensure a safe and smooth transition.
Your treatment plan will be tailored to maintain your progress.
Key Takeaway
Mounjaro® and Wegovy® are both highly effective weight loss injections. Mounjaro® uses dual hormones, while Wegovy® provides a strong, proven GLP-1 alternative with additional evidence for cardiovascular benefits. Both are most successful when combined with consistent lifestyle support. The best option for you depends on your clinical needs, personal response, and preferences.
If you still need help after reviewing the information above, additional assistance is available from the MedExpress team.